Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers
Clinical trial NCT02063594 · TERMINATED
Trial details
- NCT number
- NCT02063594
- Sponsor
- Marval Pharma Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-10-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.